SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-031332
Filing Date
2023-04-20
Accepted
2023-04-20 16:30:12
Documents
15
Period of Report
2023-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea177097-8k_inmunebio.htm   iXBRL 8-K 28926
2 FIRST AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BETWEEN INMUNE BIO INC. AND IMMUN ea177097ex10-1_inmunebio.htm EX-10.1 10337
3 SECOND AMENDMENT TO EXCLUSIVE LICENSE AGREEMENT BY AND BETWEEN THE UNIVERSITY OF ea177097ex10-2_inmunebio.htm EX-10.2 10473
4 PRESS RELEASE DATED APRIL 19, 2023 ea177097ex99-1_inmunebio.htm EX-99.1 10088
  Complete submission text file 0001213900-23-031332.txt   246422

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE inmb-20230417.xsd EX-101.SCH 2962
6 XBRL LABEL FILE inmb-20230417_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE inmb-20230417_pre.xml EX-101.PRE 22361
9 EXTRACTED XBRL INSTANCE DOCUMENT ea177097-8k_inmunebio_htm.xml XML 3712
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 23833499
SIC: 2836 Biological Products, (No Diagnostic Substances)